Rockefeller Capital Management
PCVX icon

Rockefeller Capital Management’s Vaxcyte PCVX Stock Holding History

Rockefeller Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
10,133
+254
+3% +$13.8K ﹤0.01% 2003
2026
Q1 		$574K Buy
9,879
+8,884
+893% +$482K ﹤0.01% 1901
2025
Q4 		$45.9K Buy
995
+178
+22% +$7.96K ﹤0.01% 3116
2025
Q3 		$29.4K Buy
+817
New +$27.1K ﹤0.01% 3165
2023
Q1 		– Sell
-19
Closed – – 3334
2022
Q4 		$0 Buy
+19
New +$746 ﹤0.01% 4122

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rockefeller Capital Management's PCVX Position: Q2 2026 in Review

Rockefeller Capital Management increased its Vaxcyte (PCVX) stake by 2.6% in Q2 2026, buying an estimated $13.8K and bringing the position to 10,133 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Rockefeller Capital Management first reported a position in PCVX in Q4 2022 and has held it in 5 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Rockefeller Capital Management held 10,133 shares of Vaxcyte worth $589K as of Q2 2026.
  • Rockefeller Capital Management bought 254 Vaxcyte shares in Q2 2026, an estimated $13.8K.
  • Vaxcyte made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2003 holding.
  • Rockefeller Capital Management first reported a position in Vaxcyte in Q4 2022 and has held it in 5 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.